Menshikov, M. Y. (1) und Ivanova, Krassimira und Schaefer, M. (1) und Drummer, C. und Gerzer, R. (1993) Influence of the cGMP Analog 8-PCPT-cGMP on Agonist-Induced Increasesin Cytosolic Ionized Ca2+ and on Aggregation of Human Platelets. European Journal of Pharmacology - Molecular Pharmacology Section, 245, Seiten 281-284. Elsevier Science Publishers B.V..
Dieses Archiv kann nicht den Volltext zur Verfügung stellen.
Kurzfassung
The present study was undertaken to compare inhibitory effects of the cGMP analog 8-(4-chlorophenylthio)guanosine 3`.5`-cyclic monophosphate (8-PCPT-cGMP) on increases in cytosolic ionized Ca2+ and on aggregation in human platelets induced via diverse agonists. Fura-2-loaded and gel-filtered platelets were stimulated by either ADP, thrombin, or collagen, respectively. The cGMP analog induced a concentration-dependent inhibition of cytosolic ionized Ca2+ increases and of aggregation to all agonist investigated with half-maximal inhibiting effects of approximately 100 nM. The data obtained suggest that both platelet Ca2+ exchange and aggregation have a similar sensitivity to the cGMP analog. In accordance with previously found significant differences between the potencies of nitric oxide (NO)-generating substances to inhibit increases in cytosolic ionized Ca2+ and aggregation, it appears that the anti- platelet effects of NO-releasing agents could only partially be explained by the elevation of cGMP levels.
elib-URL des Eintrags: | https://elib.dlr.de/26870/ | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dokumentart: | Zeitschriftenbeitrag | ||||||||||||||||||||||||
Zusätzliche Informationen: | LIDO-Berichtsjahr=1993, pages=4, | ||||||||||||||||||||||||
Titel: | Influence of the cGMP Analog 8-PCPT-cGMP on Agonist-Induced Increasesin Cytosolic Ionized Ca2+ and on Aggregation of Human Platelets | ||||||||||||||||||||||||
Autoren: |
| ||||||||||||||||||||||||
Datum: | 1993 | ||||||||||||||||||||||||
Erschienen in: | European Journal of Pharmacology - Molecular Pharmacology Section | ||||||||||||||||||||||||
Referierte Publikation: | Ja | ||||||||||||||||||||||||
Open Access: | Ja | ||||||||||||||||||||||||
Gold Open Access: | Ja | ||||||||||||||||||||||||
In SCOPUS: | Nein | ||||||||||||||||||||||||
In ISI Web of Science: | Ja | ||||||||||||||||||||||||
Band: | 245 | ||||||||||||||||||||||||
Seitenbereich: | Seiten 281-284 | ||||||||||||||||||||||||
Verlag: | Elsevier Science Publishers B.V. | ||||||||||||||||||||||||
Status: | veröffentlicht | ||||||||||||||||||||||||
Stichwörter: | cGMP analog, Ca2+, platelet aggregation, nitric oxide (NO) | ||||||||||||||||||||||||
HGF - Forschungsbereich: | Verkehr und Weltraum (alt) | ||||||||||||||||||||||||
HGF - Programm: | Weltraum (alt) | ||||||||||||||||||||||||
HGF - Programmthema: | W - keine Zuordnung | ||||||||||||||||||||||||
DLR - Schwerpunkt: | Weltraum | ||||||||||||||||||||||||
DLR - Forschungsgebiet: | W - keine Zuordnung | ||||||||||||||||||||||||
DLR - Teilgebiet (Projekt, Vorhaben): | W - keine Zuordnung (alt) | ||||||||||||||||||||||||
Standort: | Köln-Porz | ||||||||||||||||||||||||
Institute & Einrichtungen: | Institut für Luft- und Raumfahrtmedizin | ||||||||||||||||||||||||
Hinterlegt von: | DLR-Beauftragter, elib | ||||||||||||||||||||||||
Hinterlegt am: | 02 Apr 2006 | ||||||||||||||||||||||||
Letzte Änderung: | 11 Jul 2011 13:44 |
Nur für Mitarbeiter des Archivs: Kontrollseite des Eintrags